Baseline selection in concentration-QTc modeling: impact on assay sensitivity.

Area of Science:

• Pharmacometrics
• Clinical Pharmacology
• Drug Development

Background:

• Baseline selection is a critical but understudied aspect of concentration-QTc (C-QTc) modeling.
• Commonly used baselines (time-matched, pre-dose) may affect assay sensitivity in C-QTc models.
• Understanding baseline impact is crucial for accurate C-QTc model predictions and regulatory assessment.

Purpose of the Study:

• To investigate the impact of different baseline selections on C-QTc modeling.
• To evaluate how baseline choice affects assay sensitivity using real-world data.
• To provide guidance on optimal baseline selection for C-QTc studies.

Main Methods:

• Analysis of moxifloxacin and placebo data from over 50 FDA TQT studies.
• Examination of C-QTc model predictions using time-matched, pre-dose, and average baselines.
• Assessment of assay sensitivity and impact on categorical ΔQTc predictions.

Main Results:

• Baseline selection significantly impacts C-QTc model predictions, varying with study design (parallel vs. crossover).
• The choice of baseline does not typically alter the interpretation of the regulatory outlier threshold (ΔQTc > 60 ms).
• Subsampling data confirmed the robustness of these findings.

Conclusions:

• Baseline selection is a key factor influencing C-QTc model outcomes.
• Despite prediction variations, regulatory interpretation of significant QTc prolongation remains consistent.
• Findings offer practical guidance for designing C-QTc studies and selecting appropriate baselines.